caffeine has been researched along with 1-(3-chlorophenyl)piperazine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Geraci, MF; Klein, E; Murphy, DL; Uhde, TW; Zohar, J | 1 |
| Charney, DS; Deutsch, DN; Krystal, JH | 1 |
| Baker, GB; Bourin, M; Bradwejn, J | 1 |
| Bell, CJ; Malizia, AL; Nutt, DJ | 1 |
| Duxon, MS; Jones, N; King, SM | 1 |
| Salchner, P; Sharp, T; Singewald, N | 1 |
| Abrams, JK; Hay-Schmidt, A; Johnson, PL; Lowry, CA; Mikkelsen, JD; Shekhar, A | 1 |
| Abrams, JK; Hale, MW; Johnson, PL; Lowry, CA; Shekhar, A; Westerman, AM | 1 |
| Ahmed, SP; Alam, N; Haider, S; Haleem, DJ; Najam, R | 1 |
3 review(s) available for caffeine and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
The biological basis of panic disorder.
Topics: Brain; Caffeine; Carbon Dioxide; gamma-Aminobutyric Acid; Humans; Lactates; Norepinephrine; Panic Disorder; Piperazines; Serotonin; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Neurobiology of panic disorder.
Topics: Caffeine; Carbon Dioxide; Cholecystokinin; Humans; Neurotransmitter Agents; Panic Disorder; Piperazines; Serotonin Receptor Agonists; Sodium Lactate; Synaptic Transmission; Yohimbine | 1998 |
Brain mechanisms of social anxiety disorder.
Topics: Animals; Brain; Caffeine; Carbon Dioxide; Cholecystokinin; Dopamine; Fear; Fenfluramine; Humans; Panic Disorder; Paroxetine; Phobic Disorders; Piperazines; Rats; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Tomography, Emission-Computed | 1998 |
1 trial(s) available for caffeine and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
Topics: Adult; Anxiety Disorders; Arousal; Brain; Caffeine; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Panic Disorder; Piperazines; Prolactin; Receptors, Serotonin; Serotonin | 1991 |
7 other study(ies) available for caffeine and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Caffeine; Carbolines; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Escape Reaction; Evaluation Studies as Topic; GABA Antagonists; Male; Maze Learning; Pentylenetetrazole; Piperazines; Rats; Reaction Time; Serotonin Receptor Agonists; Yohimbine | 2002 |
Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs.
Topics: Adrenergic alpha-Antagonists; Amygdala; Animals; Anxiety; Caffeine; Carbolines; Central Nervous System Stimulants; Cerebral Cortex; Fear; GABA Antagonists; Gene Expression; Hippocampus; Hypothalamus; Immunohistochemistry; Male; Nerve Net; Piperazines; Prosencephalon; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Septum of Brain; Yohimbine | 2003 |
Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Anti-Anxiety Agents; Arousal; Behavior, Animal; Blotting, Western; Brain; Brain Mapping; Caffeine; Carbolines; Cell Count; Central Nervous System Stimulants; Feeding Behavior; GABA Antagonists; Gene Expression Regulation; Immunohistochemistry; Male; Neural Pathways; Neurons; Piperazines; Proto-Oncogene Proteins c-fos; Raphe Nuclei; Rats; Rats, Wistar; Serotonin; Serotonin Receptor Agonists; Stilbamidines; Time Factors; Tryptophan Hydroxylase; Video Recording; Yohimbine | 2005 |
Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Brain; Caffeine; Carbolines; Cell Count; gamma-Aminobutyric Acid; Gene Expression Regulation; Interneurons; Male; Parvalbumins; Piperazines; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Time Factors; Yohimbine | 2010 |
Hypophagic and hypolocomotive effects of metachloro phenyl piperazine in rats treated with theophylline and caffeine.
Topics: Animals; Caffeine; Drug Interactions; Eating; Motor Activity; Piperazines; Rats; Rats, Wistar; Serotonin Receptor Agonists; Theophylline | 2011 |